Decision Makers
| Name (plus bio) |
Position |
| David E.I. Pyott |
Chief Executive Officer |
| Dawn Hudson |
President and Chief Executive Officer of Pepsi, Cola North America |
| Michael R. Gallagher |
Chief Executive Officer |
| Michael Ball |
President |
| Douglas S. Ingram |
Chief Administrative Officer |
| Jeffrey L. Edwards |
Chief Financial Officer |
| Martin A. Voet |
Senior Vice President, Chief Intellectual Property Counsel & Assistant Secretary |
| Dianne Dyer-Bruggeman |
Executive Vice President, HR |
| Jacqueline Schiavo |
Executive Vice President, Global Technology Operations |
| Raymond H. Diradoorian |
Executive Vice President, Global Technical Operations |
| Roy Wilson |
Executive Vice President, Human Resources and Information Technology |
| Scott M. Whitcup |
Executive Vice President, Research and Development |
| James M. Hindman |
Senior Vice President, Treasury, Risk & Investor Relations |
| John R. Gibson |
Senior Vice President |
| Joshua Ofman |
Vice President, Reimbursement & Payment Policy |
| Julian Gangolli |
Corporate Vice President |
| Nelson R.A. Marques |
Vice President |
| Glenn E. Davis |
Partner |
| Thomas Albright |
Senior Director, Marketing, Botox |
| Donna M Norton |
Manager |
| James F. Barlow |
Senior Vice President, Corp. Controller (Pao) |
| Adam N Summers |
Investigator |
| Andrew Michael Blumenfeld |
Consultant |
| Bradley Calobrace |
Lecturer |
| Irina Abovsky-Akkerman |
Facial Rejuvenation Injection Trainer |
| Jamie Sherrill |
Trainer |
| Marina I Peredo |
National Education Faculty Trainer |
| Mark Ballentyne |
Trainer |
| Mary P Lupo |
Clinical Instructor |
| Matthew J. Maletta |
Assistant Secretary |
| R Samuel Bryant |
Principal Investigator |
| Stacy Vencill |
Trainer |
| Thomas Kislan |
Consultant |
| Deborah Dunsire |
Director |
| Gavin S. Herbert |
Director |
| Leonard D. Schaeffer |
Director |
| Stephen J. Ryan |
Director |
| Trevor M. Jones |
Director |
Board of Directors
| Organization |
Position |
Status |
| Allergan, Inc. |
Chief Executive Officer |
Current |
| Allergan, Inc. |
President |
Current |
| Allergan, Inc. |
Chairman |
Current |
| Pacific Mutual Holding Company |
Director |
Current |
| Edwards Lifesciences Corporation |
Director |
Current |
| Allergan, Inc. |
Director |
Current |
| California Healthcare Institute, Inc. |
Director |
Current |
| Pacific Life Insurance Company |
Board of Directors |
Current |
| Cosmetic Surgery Foundation, Inc |
Board Member |
Current |
| University of California |
Director |
Current |
| Avery Dennison Corporation |
Director |
Current |
| Biotechnology Industry Organization |
Board Member |
Current |
| Pacific LifeCorp |
Director |
Current |
| IHOP Corp. |
Chief Executive Officer |
Former |
| Novartis AG |
President, Executive Committee |
Former |
| IHOP Corp. |
President |
Former |
| IHOP Corp. |
Chief Operating Officer |
Former |
| Sandoz |
Strategic Planning and In Marketing |
Former |
| Novartis AG |
Head of the Novartis Nutrition Division |
Former |
| Novartis AG |
Board of Directors |
Former |
| London Business School |
M.B.A. |
Former |
| University of Edinburgh |
M.A. |
Former |
| Novartis AG |
Executive Committee Member |
Former |
| Avery Dennison Corporation |
member |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
President and Chief Executive Officer of Pepsi, Cola North America |
Current |
| Lgpa |
Chairperson of the Board |
Current |
| LPGA |
Chairperson of the Board |
Current |
| Allergan, Inc. |
Board of Directors |
Current |
| Organization |
Position |
Status |
| Allergan, Inc. |
Chief Executive Officer |
Current |
| University of California |
Member, Board of Advisors |
Current |
| Allergan, Inc. |
Director |
Current |
| St. Luke's School |
Board of Directors |
Current |
| Eastman Kodak Company |
Chief Executive Officer |
Former |
| Sterling Drug |
Chief Executive Officer |
Former |
| Sterling Drug |
President |
Former |
| Eastman Kodak Company |
President |
Former |
| Playtex Ltd. |
|
Former |
Mr. Ball has been President since February 2006. Mr. Ball joined Allergan in 1995, and served as Executive Vice President and President, Pharmaceuticals, since October 2003. Born in Canada, Mr. Ball was educated in the United Kingdom and United States before receiving his Bachelor of Science and Master of Business Administration degrees from Queen's University in Canada. He is the former President of Syntex Inc. Canada and Senior Vice President of Syntex Laboratories USA, where he served on Syntex Corporation's Management Committee. Mr. Ball has more than 26 years of international health care experience in the marketing and sale of pharmaceutical products.
| Organization |
Position |
Status |
| Allergan, Inc. |
President |
Current |
| Allergan, Inc. |
Senior Vice President |
Current |
| Meritech Capital Partners |
Board Member |
Current |
| Stradling Yocca Carlson & Rauth |
Board Member |
Current |
| American Surgisite Centers, Inc. |
Board Member |
Current |
| Eli Lilly and Company |
|
Former |
| Queens University |
M.B.A. |
Former |
| Queens University |
Bachelor of Science Degree |
Former |
Mr. Ingram has been Executive Vice President, Chief Administrative Officer, General Counsel and Secretary since October 2006. From October 2003 to October 2006, Mr. Ingram served as Executive Vice President, General Counsel and Secretary. Mr. Ingram joined Allergan from Gibson, Dunn & Crutcher in 1996. Mr. Ingram has more than 19 years of experience in the management of domestic and international legal affairs. Mr. Ingram manages Allergan's Global Legal Affairs, Global Regulatory Affairs, Compliance and Internal Audit, Corporate Communications, Global Trade Compliance, Global Human Resources and Information Technology organizations. Mr. Ingram is the Secretary to Allergan's Board of Directors. Mr. Ingram received his Juris Doctorate from the University of Arizona in 1988, graduating summa cum laude and Order of the Coif.
| Organization |
Position |
Status |
| Allergan, Inc. |
Chief Administrative Officer |
Current |
| Allergan, Inc. |
Secretary |
Current |
| Volcom, Inc. |
Board of Directors |
Current |
| Allergan, Inc. |
Executive Vice President |
Former |
| Allergan, Inc. |
Senior Vice President |
Former |
| Allergan, Inc. |
Corporate Vice President |
Former |
| Gibson, Dunn & Crutcher LLP |
NA |
Former |
| Allergan, Inc. |
General Counsel |
Former |
| The University of Arizona |
Juris Doctorate |
Former |
| Arizona State University |
B.A. |
Former |
| The University of Arizona |
Degree |
Former |
Mr. Edwards has been Executive Vice President, Finance and Business Development, Chief Financial Officer, since September 2005. Mr. Edwards joined Allergan in 1993. From March 2003 to September 2005, Mr. Edwards served as Corporate Vice President, Corporate Development and previously served as Senior Vice President, Treasury, Tax and Investor Relations. Prior to joining Allergan, Mr. Edwards was with Banque Paribas and Security Pacific National Bank, where he held various senior-level positions in the credit and business development functions. Mr. Edwards completed the Advanced Management Program at the Harvard Business School and received a Bachelor of Arts degree in Sociology from Muhlenberg College.
| Organization |
Position |
Status |
| Allergan, Inc. |
Chief Financial Officer |
Current |
| Allergan, Inc. |
Executive Vice President, Finance and Business Development |
Former |
| Security Pacific National Bank |
NA |
Former |
| Muhlenberg College |
Bachelor of Arts Degree In Sociology |
Former |
| Harvard Business School |
Advanced Management Program |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Senior Vice President, Chief Intellectual Property Counsel & Assistant Secretary |
Current |
| Organization |
Position |
Status |
| Allergan, Inc. |
Executive Vice President, HR |
Current |
| Broadcom Korea |
Senior Vice President, Global Human Resources |
Current |
| Broadcom Korea |
Vice President of Human Resources |
Current |
| Broadcom Corporation |
Senior Vice President, Global Human Resources |
Former |
| Titan Corporation |
Vice President, Human Resources |
Former |
| Broadcom Corporation |
Vice President of Human Resources |
Former |
| Tribune Company |
Director of Human Resources |
Former |
| Chicago Sun Times |
Manager |
Former |
| Titan Corporation |
Consultant |
Former |
| Ithaca College |
B.A. In Language |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Executive Vice President, Global Technology Operations |
Current |
| Pepperdine University |
M.B.A. |
Former |
| Cornell University |
bachelor of science degree in microbiology |
Former |
Mr. Diradoorian has been Executive Vice President, Global Technical Operations, since February 2006. From April 2005 to February 2006, Mr. Diradoorian served as Senior Vice President, Global Technical Operations. Since February 2001, Mr. Diradoorian served as Vice President, Global Engineering and Technology. Mr. Diradoorian joined Allergan in July 1981. Prior to joining Allergan, Mr. Diradoorian held positions at American Hospital Supply and with the Los Angeles Dodgers baseball team. Mr. Diradoorian received a Bachelor of Science degree in Biological Sciences from the University of California, Irvine and a Master of Science degree in Technology Management from Pepperdine University.
| Organization |
Position |
Status |
| Allergan, Inc. |
Executive Vice President, Global Technical Operations |
Current |
| S.Com, Inc. |
Executive Vice President, Global Technical Operations |
Former |
| Pepperdine University |
Master of Science Degree In Technology Management |
Former |
| American Hospital Supply Corporation |
|
Former |
| Pepperdine University |
M.S. Degree In Technology Management |
Former |
| University of California |
B.S. Degree In Biological Sciences |
Former |
| University of California, Irvine |
B.S. degree in Biological Sciences |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Executive Vice President, Human Resources and Information Technology |
Current |
| Mydials Inc. |
Executive, Russell Reynolds |
Current |
| Texchange |
Director |
Current |
| The University of Houston |
Director |
Current |
| Texas A&M University |
Director |
Current |
| BMC Software, Inc. |
Senior Vice President, Human Resources and Administration |
Former |
| Syracuse University |
bachelor of science degree |
Former |
Dr. Whitcup has been Executive Vice President, Research and Development, since July 2004. Dr. Whitcup joined Allergan in 2000. Prior to joining Allergan, Dr. Whitcup served as the Clinical Director of the National Eye Institute at the National Institutes of Health. As Clinical Director, Dr. Whitcup's leadership was vital in building the clinical research program and developing new therapies for ophthalmic diseases. Dr. Whitcup graduated from Cornell University and Cornell University Medical College. He completed residency training in internal medicine at the University of California, Los Angeles and in ophthalmology at Harvard University, as well as fellowship training in immunology at the National Institutes of Health. Dr. Whitcup is a faculty member at the Jules Stein Eye Institute/David Geffen School of Medicine at the University of California, Los Angeles.
| Organization |
Position |
Status |
| Allergan, Inc. |
Executive Vice President, Research and Development |
Current |
| National Institutes of Health |
Clinical Director |
Former |
| National Eye Institute |
Clinical Director |
Former |
| Nei, Inc. |
|
Former |
| Cornell University |
Graduate |
Former |
| Weill Medical College of Cornell University |
Graduate |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Senior Vice President, Treasury, Risk & Investor Relations |
Current |
John R. Gibson, MBChB, MRCP (UK), FRCP (Glasgow) is the Senior Vice President, Global Development at Allergan, Irvine, California. He also serves as Volunteer Clinical Professor of Dermatology, UCI, Irvine, California, and SUNY, Buffalo, New York. He received his medical degree from Glasgow University in 1973, and subsequently trained in general medicine, infectious diseases and pediatrics in Zimbabwe and the United Kingdom. Development as a Dermatologist occurred in parallel with an industry career. He was appointed Honorary Consultant Dermatologist at the Royal London Hospital, England in 1982. He has significant international (27 years) experience in all aspects of drug development with three major pharmaceutical companies (Wellcome, Bristol-Myers Squibb and Allergan); and a track record of product approvals worldwide in the fields of dermatology, ophthalmology and neurology, with additional experience in oncology, allergy and anti-infectives, including anti-virals. His passion for drug development and medicine remains powerfully intact.
| Organization |
Position |
Status |
| Allergan, Inc. |
Senior Vice President |
Current |
| Ventana Capital Management, LLC |
Pharmaceutical Industry Advisor |
Current |
| Bristol-Myers Squibb Company |
|
Current |
| British-American Business Council |
Member of the Board of Directors |
Current |
| Somanta Limited |
Director |
Current |
| State University of New York at Buffalo |
Volunteer |
Former |
| Glasgow University |
Medical Degree |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Vice President, Reimbursement & Payment Policy |
Current |
| Organization |
Position |
Status |
| Allergan, Inc. |
Corporate Vice President |
Current |
| The Armenian Eyecare Project |
Board of Directors |
Current |
| The Glaucoma Foundation |
Board of Directors |
Current |
| Allergan, Inc. |
Senior Vice President |
Former |
| Female Health Care |
Group Product Director |
Former |
| The Pain |
Group Product Director |
Former |
| Kingston University |
Bsc (Hons) In Applied Chemistry and Business Studies |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Vice President |
Current |
With over thirty years experience in the practice of food and drug law, Mr. Davis brings a unique perspective to his clients, having served both as in-house General Counsel and in private practice. Practicing initially with KKB in the 1970s and 1980s, he then spent 15 years in-house at Syntex and Allergan in California. Serving as General Counsel of several divisions of Allergan, he played a key roll in the regulatory approval, acquisition, development, launch, and highly successful marketing of BOTOX (botulinum toxin purified neurotoxin complex), as well as the development and licensing of several biologics manufacturing facilities for the product. At Allergan, he also managed the company's internal Institutional Review Board. He returned as a partner to KKB in 1998, opening the firm's West Coast office. In the professional arena, he has served as Vice Chair of the American Bar Association's Committee on Food and Drug Law. For many years, he was General Counsel of the Pharmaceutical Marketing Research Group. He has lectured on FDA law at numerous law schools and universities, including Stanford University, the University of the Pacific, and Saddleback Valley College.
| Organization |
Position |
Status |
| Kkb & Company |
Partner, Managing Attorney, West Coast Office |
Current |
| Allergan, Inc. |
Partner |
Current |
| Allergan, Inc. |
General Counsel |
Former |
| Stanford University |
|
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Senior Director, Marketing, Botox |
Current |
| Organization |
Position |
Status |
| Noblitt & Rueland |
Manager of Quality Assurance for the Information Services |
Current |
| Allergan, Inc. |
Manager |
Current |
| Organization |
Position |
Status |
| Allergan, Inc. |
Senior Vice President, Corp. Controller (Pao) |
Current |
| Allergan, Inc. |
Board of Directors |
Current |
| Allergan, Inc. |
Vice President & Controller |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Investigator |
Current |
| My Threadlift |
Clinical Assistant Professor of Plastic Surgery |
Current |
| Maryland Plastic & Cosmetic Surgery |
Clinical Assistant Professor |
Current |
| Mentor Corporation |
Investigator |
Current |
| University of Maryland |
Assistant Professor |
Current |
| Liposuction Surgeon |
|
Current |
| Southern California Plastic Surgery |
|
Current |
| All About Implants |
|
Current |
| St. Louis University School of Medicine |
|
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Consultant |
Current |
| Botox Dentalsm |
|
Current |
| Tmd Courses Inc. |
|
Current |
| American Headache Society |
Board of Directors |
Current |
| The Headache Center |
Director |
Current |
| American Headache Society |
Member |
Current |
| University of the Witwatersrand |
|
Former |
| Organization |
Position |
Status |
| Calobrace Plastic Surgery Center |
Plastic Surgeon |
Current |
| Mentor Corporation |
Consultant |
Current |
| Allergan, Inc. |
Lecturer |
Current |
| Implantinfo |
Board Certified Plastic Surgeon In Louisville, Kentucky |
Current |
| Liposite |
|
Current |
| Implantinfo |
Board of Directors |
Current |
| American College of Surgeons |
Fellow |
Current |
| Indiana University School of Medicine |
|
Former |
Irina Akkerman, FNP, MSN, Board Certified, LaserDoc Clinical Director, with more than 10 years of Laser Skin Care. Irina is a successful nurse practitioner with a masters in nursing science. She is a busy wife and mother of two children. An avid kick boxer, passionate believer in the power of exercise and positive energy. Irina is an expert in all forms of facial rejuvenation. She specalizes in correcting sun damaged skin and providing anti-aging skin and body care. She is expert in the use of Advanced FDA approved Pixel Fractional Resurfacing, Scar revisions, Harmony IPL Treatments, Laser Hair Removal, Accent XL Body and Face Treatments, Laser Leg Vein Therapy, Medical grade infusion system microdermabrasion, Acne treatement, Acne scar revision, and Preventive Skin Care Maintenance. LaserDoc is a premiere provider of Botox and Juvederm by Allergan. Irina is an Botox and Juvederm facial rejuvenation injection trainer for Allergan. As a leader in ALMA laser technology, we are certified laser trainers for ALMA Lasers. She is expert at tailoring our LaserDoc physician supervised Clinical Skin Care system to suit each individual and she will be your educator and guide during your Consultation and allow you to plan the aesthetic, health care and anti-aging goals you desire to achieve.
| Organization |
Position |
Status |
| Allergan, Inc. |
Facial Rejuvenation Injection Trainer |
Current |
| The Laserdoc Skincare Center |
Board of Directors |
Current |
As a published author, licensed pilot, and Registered Nurse, Jamie Sherrill is a woman of many talents. Upon first meeting her, her sense of humor and beauty belie her stature as cosmetic nurse to the stars in one of LA?s most elite medical spas. Pursued by medical spas across the country; however, exclusively employed by Belle Visage-- Nurse Jamie has performed countless injections, laser treatments and all forms of minor cosmetic surgeries both in her medical suite and on-site at the homes of the rich and famous. She believes she is doing her part to make the world a better place one hair and one wrinkle at a time. From housewives to A-list actresses, models to Hollywood?s leading men, Jamie?s scientific and research background has been tapped to provide an honest assessment of the latest trends, do?s and don?ts and red carpet secrets. In fact, Nurse Jamie has been sought after by every major media outlet for her cover girl looks, approachability and years of unparalleled expertise. She has the unique perspective of having watched the industry grow from its infancy to a multi-billion dollar business and coupled with her contagious enthusiasm, she has been tapped by shows such as Extra! Fashion Team, KTLA, Good Day LA and Queer Eye for the Straight Guy to give a sneak peek into the hidden world of celebrity cosmetic treatments. Encouraged by her celebrities clients and producers who recognized her natural on-camera persona, Jamie also began to pursue her love of acting, appearing in movies such as Dragonfly and a recurring roles as a nurse on Days of Our Lives, Untold Stories of the ER and most recently as a series regular on The Simple Life. Nurse Jamie entered the world of plastic surgery when she was handpicked for training as a teenager working for a plastic surgeon. Since beginning to perform treatments at a tender age, Jamie has been placed on the short list of go-to experts laser manufactures rely upon to test the latest technology and evangelize treatments to her high-profile clients. A pioneer in the industry, Jamie has also been chosen to lead multiple alpha test sites for laser manufacturers where she develops parameters for laser effectiveness, as well as safety usage guidelines for doctors. Jamie has over 10 years of injecting experience and is a trainer for CME Scholar/ Allergan?she trains others nurses and doctors on how to skillfully inject Botox and Juvederm. As the youngest of three girls raised on a farm in Southern Indiana who made her way to Beverly Hills, Nurse Jamie makes the world of Hollywood style accessible to everyone from stars to those who only read about it in the magazines. Additionally, she is author of Nurse Jamie?s Botox Diaries: Real Stories from a Fake World, a tell-all book that documents her medical spa experiences from the inspiring to the bizarre.
| Organization |
Position |
Status |
| Allergan, Inc. |
Trainer |
Current |
| Nurse Jamie |
|
Current |
| Organization |
Position |
Status |
| Allergan, Inc. |
National Education Faculty Trainer |
Current |
| Lifebotanica |
Board of Directors |
Current |
| The Skin Cancer Foundation |
Board of Directors |
Former |
Dr. Mark Ballentyne is a highly skilled physician who has been Director of Medical Aesthetics at the Skin Wellness Center for five years. He has established a strong reputation for his talent in performing the lip augmentation procedure, facial treatments with BOTOX Cosmetic injections and dermal fillers, photorejuvenation, sclerotherapy, medical level skin care treatments, and chemical peels. Dr. Ballentyne has helped many women and men achieve a more youthful appearance. His patients also benefit from Dr. Ballentyne's team approach to treatment, as he often collaborates with Dr. Lawrence N. Gray in caring for patients. In order to offer his patients the latest and safest treatments, Dr. Ballentyne attends various academic conferences, where he meets with other doctors to explore and discuss advances and innovations in aesthetic medicine. He has been invited to be a national trainer for Allergan , maker of some of the world's most popular dermal fillers, due to his technical skill, extensive experience, and eye for superior results. He is also frequently asked to demonstrate cosmetic injection methods to other doctors. A trait that sets Dr. Ballentyne apart from many other physicians is his ability to listen carefully to his patients, a skill he honed during his experience as a family practitioner. The attention he pays to his patients' goals and needs allows him to provide them with the highest possible quality of care.
| Organization |
Position |
Status |
| Skin Wellness Center |
Director of Medical Aesthetics |
Current |
| Allergan, Inc. |
Trainer |
Current |
| Atlantic Plastic Surgery Center |
Board of Directors |
Current |
| Organization |
Position |
Status |
| Tulane University School of Medicine |
Clinical Professor |
Current |
| Allergan, Inc. |
Clinical Instructor |
Current |
| Dermik |
Instructor |
Current |
| Dr. Mary Lupo Skin Care Products, Inc. |
|
Current |
| Women's Dermatologic Society |
First, Year Board Representative |
Current |
| Women's Dermatologic Society |
President |
Former |
| Women's Dermatologic Society |
Vice President |
Former |
| Laser , Inc |
Program Director |
Former |
| Laser , Inc |
Faculty Member |
Former |
| Laser , Inc |
Board of Directors |
Former |
| Organization |
Position |
Status |
| Allergan, Inc. |
Assistant Secretary |
Current |
Array
| Organization |
Position |
Status |
| Plastic Surgical Arts |
|
Current |
| University of Nebraska - Lincoln |
|
Former |
Array
| Organization |
Position |
Status |
| Professional Skin Concepts Medspa |
|
Current |
Dr. Thomas Kislan is the founder and medical director of Stroudsburg Eye Specialists (est. 1999), Hazleton Eye Specialists (est. 2001) and Dry Eye Clinic of Northeastern PA (est. 2002). These practices are large multi-disciplinary eye care facilities which provide routine medical eye care and the treatment and management of ocular diseases, such as cataracts, glaucoma, dry eye disease, diabetic retinopathy and macular degeneration. Dr. Kislan completed undergraduate study at Wilkes University and received his Doctor of Optometry from the Pennsylvania College of Optometry in Philadelphia. He completed internships at the Lynch Pediatric unit in Philadelphia, the Wilkes-Barre VA Medical Center and the Trachtenberg Moran Eye Surgery Center in Allentown, PA. Dr. Kislan is an educational lecturer and speaks nationally on Dry Eye Disease, Glaucoma, Ophthalmic use of Omega 3 Fatty Acids and the management of Refractive Surgery. Dr. Kislan participates in clinical research and has presented this research at many national meetings. This research has also been published in peer-reviewed journals. Dr. Kislan is a consultant for Allergan, AMO, Lifeguard Health and Pfizer pharmaceuticals. Dr. Kislan is also the host of Eye Care Today. This is a monthly show which airs on local Hazleton Channel 13 and is syndicated nationally on the web at ssptv.com. Dr. Kislan sees patients of all ages. He resides in Drums, PA with his wife, Dr. Sandra Krokos and their 5 year old son, Ryan. Dr. Kislan enjoys golf and traveling when he is not helping patients see better.
| Organization |
Position |
Status |
| Allergan, Inc. |
Consultant |
Current |
| Lifeguard Health, LLC |
Consultant |
Current |
| Dr. Kislan |
|
Current |
| Organization |
Position |
Status |
| HLM Venture Partners |
Managing Partner |
Current |
| Allergan, Inc. |
Chairperson |
Current |
| Friends School of Baltimore |
Director |
Current |
| Friends' School |
Board of Directors |
Current |
| Somalogic |
Advisor To Board of Directors |
Current |
| Phreesia |
Director |
Current |
| Prism Education Group, Inc. |
Board of Directors |
Current |
| HLM Venture Partners |
President |
Former |
| Chesapeake Strategic Advisors, LLC |
President |
Former |
| Chesapeake Strategic Advisors, LLC |
Managing Director |
Former |
| HLM Venture Partners |
Managing Director |
Former |
| Chesapeake Strategic Advisors, LLC |
Founder |
Former |
| HLM Venture Partners |
Global Co-Head |
Former |
| Deutsche Bank AG |
|
Former |
| Wharton Graduate School of the University of Pennsylvania |
M.B.A. Degree In Finance |
Former |
| United States Military Academy |
B.S. Degree |
Former |
| University of Washington |
B.S. Degree In Zoology and Ecology |
Former |
| Organization |
Position |
Status |
| PhRMA |
Board Member |
Current |
| Millennium Pharmaceuticals, Inc. |
Director |
Current |
| The G&P Foundation for Cancer Research |
Board of Directors |
Current |
| Allergan, Inc. |
Director |
Current |
| Pharmaceutical Research and Manufacturers of America |
Board Member |
Current |
| Museum of Science |
Board Member |
Current |
| Cancercare |
Board Member |
Current |
| Millennium Pharmaceuticals, Inc. |
CEO |
Former |
| Millennium Pharmaceuticals, Inc. |
President |
Former |
| Novartis AG |
Senior Vice President |
Former |
| Novartis AG |
Vice President, Oncology Business Unit |
Former |
| Novartis AG |
Head of North American Oncology Operations |
Former |
| Sandoz |
Product Management, Scientific Development & Clinical Research |
Former |
| Rigid Building Systems Ltd. |
|
Former |
| University of the Witwatersrand |
Graduate of the Medical School |
Former |
| University Corp. |
|
Former |
Array
| Organization |
Position |
Status |
| Roger's Gardens |
Chairman |
Current |
| Doheny Eye Institute |
Board of Directors |
Current |
| University of Southern California |
Board of Directors |
Current |
| Allergan, Inc. |
Director |
Current |
| Allergan, Inc. |
Chief Executive Officer |
Former |
| Allergan, Inc. |
Founder |
Former |
| Doheny Eye Institute |
Director of Research |
Former |
| Prevent Blindness |
Director of Research |
Former |
| Southern California University |
Trustee |
Former |
| Allergan, Inc. |
Chairman |
Former |
| Organization |
Position |
Status |
| Genentech, Inc. |
Co Founder |
Current |
| University of California, San Francisco |
Professor of Biochemistry |
Current |
| Genentech, Inc. |
Board of Directors |
Current |
| Allergan, Inc. |
Vice Chairman |
Current |
| National Academy of Sciences |
Board of Directors |
Current |
| Allergan, Inc. |
Board of Directors |
Former |
| National Academy of Sciences |
Member |
Former |
| Organization |
Position |
Status |
| Great Lakes Chemical Corp |
Executive Vice President and Chief Financial Officer |
Current |
| Innophos, Inc |
Board of Directors |
Current |
| Sappi Limited |
Board of Directors |
Current |
| Allergan, Inc. |
Board of Directors |
Current |
| Webster Financial Corporation |
Board of Directors |
Current |
| Mead Corporation |
Chief Financial Officer |
Former |
| MeadWestvaco Corporation |
Chief Financial Officer |
Former |
| Chemtura Corporation |
Chief Financial Officer |
Former |
| Connecticut, Inc. |
Chief Financial Officer |
Former |
| Connecticut, Inc. |
Executive Vice President |
Former |
| Chemtura Corporation |
Executive Vice President |
Former |
| MeadWestvaco Corporation |
Senior Vice President |
Former |
| Tenneco, Inc. |
Vice President |
Former |
| Reable Therapeutics, Inc. |
Board of Directors |
Former |
| Tenneco, Inc. |
Treasurer |
Former |
| Chemtura Corporation |
Board of Directors |
Former |
| Columbia University |
M.B.A. In Finance |
Former |
| Smith College |
B.A. In Latin American Studies |
Former |
| Organization |
Position |
Status |
| WellPoint, Inc. |
Board of Directors |
Current |
| Amgen Inc. |
Board of Directors |
Current |
| Allergan, Inc. |
Director |
Current |
| Anthem Life Insurance Company |
|
Former |
| WellPoint, Inc. |
Chairman |
Former |
| Organization |
Position |
Status |
| BMC Software, Inc. |
Chairman |
Current |
| Equinix, Inc. |
Board of Directors |
Current |
| Allergan, Inc. |
Board of Directors |
Current |
| Kyphon, Inc. |
Board of Directors |
Current |
| Genentech, Inc. |
Chief Financial Officer |
Former |
| Genentech, Inc. |
Executive Vice President |
Former |
| Genentech, Inc. |
controller |
Former |
| Genentech, Inc. |
Chairman |
Former |
| BMC Software, Inc. |
Board of Directors |
Former |
| Arena Pharmaceuticals, Inc. |
Board of Directors |
Former |
| Temple University |
master's degree in business administration |
Former |
| Babson College |
bachelor's degree in business administration |
Former |
| Genentech, Inc. |
member |
Former |
| Organization |
Position |
Status |
| Beckman Instruments, Inc. |
Chairman |
Current |
| Allergan, Inc. |
Board of Directors |
Current |
| Beckman Instruments, Inc. |
Chief Executive Officer |
Former |
| Beckman Coulter, Inc. |
Chairman Emeritus |
Former |
| Organization |
Position |
Status |
| CEO Roundtable, LLC |
Founder |
Current |
| Hatteras Venture Partners |
General Partner |
Current |
| Sebio |
|
Current |
| OSI Pharmaceuticals, Inc. |
Chairman of the Board |
Current |
| Cvmanager Group Corporation |
Chairman of the Board |
Current |
| Hatteras Venture Partners |
Board of Directors |
Current |
| Nortel Networks Corporation |
Board of Directors |
Current |
| Allergan, Inc. |
Board of Directors |
Current |
| Rda-Summit, LLC. |
Vice Chairman, Pharmaceuticals Glaxosmithkline |
Current |
| Valeant Pharmaceuticals International |
Board of Directors |
Current |
| Cree, Inc. |
Vice Chairman |
Current |
| Edwards Lifesciences Corporation |
Board of Directors |
Current |
| Partnership for Public Service |
Vice Chairman Pharmaceuticals, Glaxosmithkline |
Current |
| Jennerex Biotherapeutics, Inc. |
Board of Directors |
Current |
| Cree, Inc. |
Board of Directors |
Current |
| GlaxoSmithKline Plc |
President |
Former |
| GlaxoSmithKline Plc |
Chief Operating Officer |
Former |
| Merck & Co. Inc. |
Vice President of Public Affairs |
Former |
| Corporate Governance |
Chairman |
Former |
| OSI Pharmaceuticals, Inc. |
Director |
Former |
| Eastern Illinois University |
B.S. Degree In Business Administration |
Former |
| Organization |
Position |
Status |
| Keck School of Medicine |
President |
Current |
| Doheny Eye Institute |
President |
Current |
| Allergan, Inc. |
Director |
Current |
| Ophthalmology, Ltd. |
President |
Former |
| The Macula Society |
President |
Former |
| University of Southern California |
Senior Vice President for Medical Care |
Former |
| University of Southern California |
Dean of the Keck School of Medicine |
Former |
| Southern California University |
|
Former |
| The Macula Society |
Member |
Former |
Professor Trevor Jones CBE PhD DSc FKC FPS CChem FRSC MCPP FFPM has been Chairman of ReNeuron since February 1999. He recently retired as Director General of the Association of the British Pharmaceutical Industry (ABPI), the body representing the interests of some 100 national and international pharmaceutical companies. He was, until 1994, the Main Board Director responsible for Research and Development at Wellcome plc. He was responsible for the development of a number of significant new products at Wellcome, including Zovirax (anti-herpes), Retrovir (anti-HIV), Malarone (Malaria) and Lamictal (anti-epileptic). He is visiting professor, Deputy Chair of Council and Fellow of Kings College London, and is a member of the Board of Allergan Inc.
| Organization |
Position |
Status |
| King's College London |
Visiting Professor |
Current |
| King's College |
Professor |
Current |
| TI Pharma |
|
Current |
| Ff&P Private Equity Limited |
|
Current |
| King's College London |
Deputy Chairman |
Current |
| Reneuron Group Plc |
Deputy Chairman |
Current |
| Javelin Ventures Limited |
Chairman |
Current |
| Synexus Ltd |
Chairman |
Current |
| People Inc. |
Chairman of the Board of Directors |
Current |
| People In Health |
Chairman |
Current |
| Ukscf |
Board of Directors |
Current |
| SciClone Pharmaceuticals, Inc. |
Board of Directors |
Current |
| Verona Pharma Plc |
Board of Directors |
Current |
| Allergan, Inc. |
Director |
Current |
| Libertas Capital Plc |
Board of Directors |
Current |
| Rhinopharma Ltd |
Board of Directors |
Current |
| King's College |
Vice-Chair |
Current |
| The Royal Society |
Fellow |
Current |
| British Pharmacological Society |
Fellow |
Current |
| Allergan, Inc. |
Member |
Current |
| Health-Corp |
Chairman of the Board |
Former |
| Abpi |
Director |
Former |
| University of London |
Ph.D. |
Former |
| University of Athens |
Honorary Doctorate |
Former |
| University of London |
Bachelor of Pharmacy Degree |
Former |
| Organization |
Position |
Status |
| LabOne, Inc. |
|
Current |
| First Responders Financial LLC |
Board of Directors |
Current |
| Quest Diagnostics Incorporated |
Board of Directors |
Current |
| Vasogen, Inc. |
Board of Directors |
Current |
| Massey Energy Company |
Board of Directors |
Current |
| Allergan, Inc. |
Board Member |
Current |
| Ocular Sciences, Inc. |
Board Member |
Current |
| MacKay-Shields Financial Corp. |
President |
Former |
| Smith Barney |
President |
Former |
| Galen Partners |
Co-founder |
Former |
| Advanced Medical Optics, Inc. |
Chairman |
Former |
| Vasogen, Inc. |
Chairman of the Board |
Former |
| MacKay-Shields Financial Corp. |
Chairman |
Former |
| Advanced Medical Optics, Inc. |
Director |
Former |
| Smith Barney |
Vice-Chairman |
Former |
| GlaxoSmithKline Plc |
Director |
Former |
| GlaxoSmithKline Plc |
Vice Chairman |
Former |
| Marion Laboratories |
Investor |
Former |
| American Hospital Supply Corporation |
Investor |
Former |
| SmithKline Beecham Corporation |
Investor |
Former |
Executive News
-
Allergan Inc. (AGN) Receives FDA Approval for OZURDEX Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
BioSpace - 6/18/09 - View Story
-
Allergan Receives FDA Approval for Ozurdex Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
Pharma Live - 6/18/09 - View Story
-
Allergan Receives FDA Approval for OZURDEX(TM) Biodegradable, Injectable Steroid Implant with...
Forbes.com - 6/18/09 - View Story
-
Allergan Receives FDA Approval for OZURDEX„ Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease
Business Wire - 6/18/09 - View Story
-
Plump it up: longer, thicker eyelashes by prescription
South China Morning Post - 6/15/09 - View Story
-
CORRECT: Takeda's Millennium Looking For Deals To Bolster Pipeline
CNN Money - 6/02/09 - View Story
-
FDA Delays Approval of Allergan Inc. (AGN)'s Botox to Treat Spasticity
BioSpace - 5/27/09 - View Story
-
Allergan Receives Complete Response Letter for BOTOX® (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults
Reuters - 5/26/09 - View Story
-
Allergan Receives Complete Response Letter for BOTOX(R) (Botulinum Toxin Type A) for Treatment...
Forbes.com - 5/26/09 - View Story
-
Allergan Receives Complete Response Letter for BOTOX (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults
Business Wire - 5/26/09 - View Story